ACTR-29. KETOGENIC DIETS AS AN ADJUVANT THERAPY IN GLIOBLASTOMA (KEATING): A MIXED METHOD APPROACH TO ASSESSING TRIAL FEASIBILITY.

BACKGROUND: There is increasing interest in the use of ketogenic diets (KD) as adjuvant therapy for glioblastoma (GBM). This trial aimed to: (i) investigate protocol feasibility, (ii) measure patient/carer acceptability and (iii) inform phase III trial design. METHODS: A prospective, randomised, fea...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Martin-McGill, Kirsty, Cherry, Gemma, Marson, Anthony, Smith, Catrin Tudur, Jenkinson, Michael
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2018
Onderwerpen:
Abstracts
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216175/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.062
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items